tirzepatide inyectable New version of diabetes drug Mounjaro approved for weight loss by FDA tirzepatide que es y para

While neither peptide requires FDA prescription approval, medical supervision is strongly recommended for optimal results and safety monitoring

Blood sugar control In a 2021 clinical trial comparing the active ingredients of Mounjaro (tirzepatide) and Ozempic (semaglutide), researchers found tirzepatide to be more effective at lowering both blood sugar and weight in people with type 2 diabetes

Data now demonstrates that patients receiving a placebo alongside behavioral therapy lost only 2.8% of their starting weight after 24 weeks, while those who added phentermine experienced weight loss of 5.9%

Your Morning Brew and GLP-1s: Can You Drink Coffee While Taking Ozempic